arrow
Back
J

Josef S Smolen

Medical University of Vienna

87H-index
532Paper Count
3.8WCitation Count
Published Papers 167
Publication Date
The impact of comorbidities on the efficacy of IL-6 inhibitor olokizumab compared to adalimumab in a randomized controlled trial
err2025-11-18
err0
errOAAI
errEugen Feist; Michael E. Luggen; Evgeny L. Nasonov; Sergey S. Yakushin; Daria V. Bukhanova; Alina N. Egorova; Sergey A. Grishin; Mikhail Y. Samsonov; Josef S. Smolen
errShare
errSave
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis
err2025-07-12
err0
errOAAI
errGerd Burmester; Jakub Trefler; Artur Racewicz; Janusz Jaworski; Agnieszka Zielińska; Marek Krogulec; Sławomir Jeka; Rafał Wojciechowski; Katarzyna Kolossa; Anna Dudek; Magdalena Krajewska-Włodarczyk; Paweł Hrycaj; Piotr Adrian Klimiuk; SungHyun Kim; JeeHye Suh; GoEun Yang; YunAh Kim; YooBin Jung; GaHee Park; Josef S. Smolen
errShare
errSave
Global Recruiting Patterns Affect Placebo Response Rates In Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis
err2025-06-30
err0
PREAI
errAndreas Kerschbaumer MD PhD; Marlene Steiner MSc; Suzanne Khalili MD; Azad Shehab MD; Alexander Jordanov MD; Brigitte Wildner; Magdalena Maad BSc; Josef S. Smolen; Daniel Aletaha
errShare
errSave
Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study
err2025-01-15
err0
PREAI
errBurmester, Gerd; Klimiuk, Piotr Adrian; Trefler, Jakub; Jaworski, Janusz; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Lee, Hyunseung; Jang, Jiyoung; Hwang, Chankyoung; Lee, Hojae; Smolen, Josef S.
errShare
errSave
Patient Profiles in Randomized Controlled Trials Versus a Real-World Study in Psoriatic Arthritis: Scoping Review and Metaanalysis
err2024-11-15
err0
PREAI
errAlle, Gelsomina; Lopez-Medina, Clementina; Siebert, Stefan; Lavie, Frederic; Noel, Wim; Smolen, Josef S.; Gossec, Laure
errShare
errSave
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses
err2024-07-01
err0
errOAAI
errFitzgerald, Oliver; Gladman, Dafna D.; Mease, Philip J.; Ritchlin, Christopher; Smolen, Josef S.; Gao, Lu; Hu, Yanhua; Nowak, Miroslawa; Banerjee, Subhashis; Catlett, Ian
errShare
errSave
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open-label, single-dose phase I study
err2024-06-21
err1
errOAAI
errYu, Kyung-Sang; Ryu, Hyunwook; Shin, Dongseong; Park, Minkyu; Hwang, Jungi; Moon, Seol Ju; Kim, Min-Gul; Keystone, Edward; Smolen, Josef S.; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Jang, Jiyoung; Yang, Goeun; Bae, Jihun; Lee, Jaeyong; Burmester, Gerd R.
errShare
errSave
errShare
errSave
ROLE OF DENDRITIC CELLS IN ARTHRITIS AND OSTEOCLASTOGENESIS
err2024-06-01
err0
PREAI
errMazzucato-Puchner, A.; Simader, E.; Saferding, V.; Hofmann, M.; Kieler, M.; Pfeifle, R.; Kroenke, G.; Smolen, J. S.; Hayer, S.; Steiner, G.; Aletaha, D.; Blueml, S.
errShare
errSave
DO HIGH RHEUMATOID FACTOR LEVELS IMPACT RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH INADEQUATELY CONTROLLED RHEUMATOID ARTHRITIS? A POST HOC ANALYSIS OF THE PHASE 3B REALISTIC TRIAL
err2024-06-01
err0
PREAI
errSmolen, J. S.; Mikuls, T.; Galloway, J.; Mueller-Ladner, U.; Curtis, J. R.; Hashimoto, M.; Takeuchi, T.; Choy, E.; Tanaka, Y.; Cara, C.; Lauwerys, B.; Tilt, N.; Ufuktepe, B.; Taylor, P. C.
errShare
errSave
Amino Acids Fueling Fibroblast-Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration
err2024-01-17
err3
errOAAI
errKaronitsch, Thomas; Saferding, Victoria; Kieler, Markus; von Dalwigk, Karolina; Tosevska, Anela; Heller, Gerwin; Dellinger, Mirjam; Niederreiter, Birgit; Kartnig, Felix; Steiner, Carl W.; Georgel, Philippe; Kiener, Hans P.; Smolen, Josef S.; Korb-Pap, Adelheid; Bonelli, Michael; Aletaha, Daniel; Blueml, Stephan
errShare
errSave
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis
err2024-01-01
err2
errOAAI
errZhang, Xuan; Xia, Jun; Jiang, Ying; Pisetsky, David S.; Smolen, Josef S.; Mu, Rong; Dai, Shengming; Weinblatt, Michael E.; Kvien, Tore K.; Li, Juan; Doerner, Thomas; Zhang, Yu; Lu, Liwei; Yang, Chengde; Yang, Pingting; Zhang, Yuan; Xu, Chenchen; Zhao, Zhan; Lipsky, Peter E.
errShare
errSave
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries
err2023-05-01
err2
errOAAI
errSousa, Marlene; Lubrano, Ennio; Smolen, Josef S.; Gorlier, Clemence; de Wit, Maarten; Coates, Laura C.; Kalyoncu, Umut; Ruyssen-Witrand, Adeline; Leung, Ying-Ying; Scrivo, Rossana; Canete, Juan D.; Palominos, Penelope; Meisalu, Sandra; Balanescu, Andra; Kiltz, Uta; Aydin, Sibel Zehra; Gaydukova, Inna; Dernis, Emmanuelle; Fautrel, Bruno; Orbai, Ana-Maria; Gossec, Laure
errShare
errSave
American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision
err2022-10-23
err27
errOAAI
errStudenic, Paul; Aletaha, Daniel; de Wit, Maarten; Stamm, Tanja A.; Alasti, Farideh; Lacaille, Diane; Smolen, Josef S.; Felson, David T.
errShare
errSave
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
err2022-09-12
err24
errOAAI
errMrak, Daniel; Sieghart, Daniela; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Goeschl, Lisa; Koblischke, Maximilian; Hommer, Nikolaus; Wagner, Angelika; Mayer, Margareta; Schubert, Lorenz; Hartl, Lukas; Kozbial, Karin; Hofer, Philipp; Kartnig, Felix; Hummel, Thomas; Kerschbaumer, Andreas; Deimel, Thomas; Puchner, Antonia; Gudipati, Venugopal; Thalhammer, Renate; Munda, Petra; Uyanik-Uenal, Keziban; Zuckermann, Andreas; Novacek, Gottfried; Reiberger, Thomas; Garner-Spitzer, Erika; Reindl-Schwaighofer, Roman; Kain, Renate; Winkler, Stefan; Smolen, Josef S.; Stiasny, Karin; Fischer, Gottfried F.; Perkmann, Thomas; Haslacher, Helmuth; Zeitlinger, Markus; Wiedermann, Ursula; Aberle, Judith H.; Aletaha, Daniel; Heinz, Leonhard X.; Bonelli, Michael
errShare
errSave
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis
err2022-08-25
err33
errOAAI
errSmolen, Josef S.; Feist, Eugen; Fatenejad, Saeed; Grishin, Sergey A.; Korneva, Elena, V; Nasonov, Evgeniy L.; Samsonov, Mikhail Y.; Fleischmann, Roy M.
errShare
errSave
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naive Patients With Psoriatic Arthritis
err2022-04-15
err6
errOAAI
errMease, Philip J.; Kavanaugh, Arthur; Ogdie, Alexis; Wells, Alvin F.; Bergman, Martin; Gladman, Dafna D.; Richter, Sven; Teng, Lichen; Jardon, Shauna; Smolen, Josef S.
errShare
errSave
Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis
err2021-07-23
err13
errOAAI
errStudenic, Paul; Alunno, Alessia; Sieghart, Daniela; Bang, Holger; Aletaha, Daniel; Blueml, Stephan; Haslacher, Helmuth; Smolen, Josef S.; Gerli, Roberto; Steiner, Gunter
errShare
errSave
microRNA-146a controls age-related bone loss
err2020-10-21
err31
errOAAI
errSaferding, Victoria; Hofmann, Melanie; Brunner, Julia S.; Niederreiter, Birgit; Timmen, Melanie; Magilnick, Nathaniel; Hayer, Silvia; Heller, Gerwin; Steiner, Guenter; Stange, Richard; Boldin, Mark; Schabbauer, Gernot; Weigl, Moritz; Hackl, Matthias; Grillari, Johannes; Smolen, Josef S.; Blueml, Stephan
errShare
errSave